Vaccination with mannan protects mice against systemic aspergillosis

References

• Stevens DA. Vaccinate against aspergillosis! A call to arms of the immune system. Clin Infect Dis 2004; 38: 1131–1136.
   PubMed Web of Science ®Google Scholar
• Stevens DA, Clemons KV, Liu M. Developing a vaccine against aspergillosis. Med Mycol 2010; 49 (Suppl. 1): S170–S176.
   Web of Science ®Google Scholar
• Liu M, Capilla J, Johansen ME, . Saccharomyces as a vaccine against systemic aspergillosis: ‘the friend of man’ a friend again? J Med Microbiol 2011; 60: 1423–1432.
   PubMed Web of Science ®Google Scholar
• Capilla J, Clemons KV, Liu M, Levine HB, Stevens DA. Saccharomyces cerevisiae as a vaccine against coccidioidomycosis. Vaccine 2009; 27: 3662–3668.
   PubMed Web of Science ®Google Scholar
• Liu M, Clemons K, Johansen M, . Saccharomyces as a vaccine against systemic candidiasis. In: 50th Interscience Conference on Antimicrobial Agents and Chemotherapy Boston, MA; 2010:abstr G1 – 1656.
   Google Scholar
• Majumder T, Liu M, Chen V, . Killed Saccharomyces cerevisiae protects against lethal challenge with Cryptococcus grubii. In: 51st Interscience Conference on Antimicrobial Agents and Chemotherapy; 2011; Chicago: American Society for Microbiology; 2011: Abstr. G1 – 769.
   Google Scholar
• Jennings HJ. Capsular polysaccharides as human vaccines. Adv Carbohydr Chem Biochem 1983; 41: 155–208.
   PubMed Web of Science ®Google Scholar
• Bystricky S, Paulovicova E, Machova E. Candida albicans mannan-protein conjugate as vaccine candidate. Immunol Lett 2003; 85: 251–255.
   PubMedGoogle Scholar
• Robbins JB, Schneerson R. Polysaccharide-protein conjugates: a new generation of vaccines. J Infect Dis 1990; 161: 821–832.
   PubMed Web of Science ®Google Scholar
• Pelizon AC, Kaneno R, Soares AM, Meira DA, Sartori A. Immunomodulatory activities associated with beta-glucan derived from Saccharomyces cerevisiae. Physiol Res 2005; 54: 557–564.
   PubMed Web of Science ®Google Scholar
• Ližičárová I, Matulová M, Capek P, Machová E. Human pathogen Candida dubliniensis: a cell wall mannan with a high content of β-1,2-linked mannose residues. Carbohydr Polym 2007; 70: 89–100.
   Web of Science ®Google Scholar
• Jones JKN, Stoodley RJ. Fractionation using copper complexes. In: Whistler RL, ed. Methods in Carbohydrate ChemistryV. New York: Academic Press, 1965: 36–38.
   Google Scholar
• Bystricky S, Machova E, Bartek P, Kolarova N, Kogan G. Conjugation of yeast mannans with protein employing cyanopyridinium agent (CDAP) – an effective route of antifungal vaccine preparation. Glycoconj J 2000; 17: 677–680.
   PubMed Web of Science ®Google Scholar
• Lees A, Nelson BL, Mond JJ. Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents. Vaccine 1996; 14: 190–198.
   PubMed Web of Science ®Google Scholar
• Dubois M, Gilles KS, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956; 28: 350–356.
   Web of Science ®Google Scholar
• Sedmak JJ, Grossberg SE. A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250. Anal Biochem 1977; 79: 544–552.
   PubMed Web of Science ®Google Scholar
• Clemons KV, Espiritu M, Parmar R, Stevens DA. Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis. Antimicrob Agents Chemother 2005; 49: 4867–4875.
   PubMed Web of Science ®Google Scholar
• Clemons KV, Grunig G, Sobel RA, . Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis. Clin Exp Immunol 2000; 122: 186–191.
   PubMed Web of Science ®Google Scholar
• Clemons KV, Miller TK, Selitrennikoff CP, Stevens DA. fos-1, a putative histidine kinase as a virulence factor for systemic aspergillosis. Med Mycol 2002; 40: 259–262.
   PubMed Web of Science ®Google Scholar
• Hanson LH, Clemons KV, Denning DW, Stevens DA. Efficacy of oral saperconazole in systemic murine aspergillosis. J Med Vet Mycol 1995; 33: 311–317.
   PubMedGoogle Scholar
• Clemons KV, Stevens DA. The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence. Med Mycol 2005; 43(Suppl. 1): S101–S110.
   Google Scholar
• Lachin JM. Worst-rank score analysis with informatively missing observations in clinical trials. Control Clin Trials 1999; 20: 408–422.
   PubMedGoogle Scholar
• Shih W. Problems in dealing with missing data and informative censoring in clinical trials. Curr Control Trials Cardiovasc Med 2002; 3: 4.
   PubMedGoogle Scholar
• Xin H, Dziadek S, Bundle DR, Cutler JE. Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci USA 2008; 105: 13526–13531.
   PubMed Web of Science ®Google Scholar
• Han Y, Ulrich MA, Cutler JE. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J Infect Dis 1999; 179: 1477–1484.
   PubMed Web of Science ®Google Scholar
• Torosantucci A, Bromuro C, Chiani P, . A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 2005; 202: 597–606.
   PubMed Web of Science ®Google Scholar
• Pirofski LA. Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens. Trends Microbiol 2001; 9: 445–451.
   PubMed Web of Science ®Google Scholar
• Han Y, Cutler JE. Antibody response that protects against disseminated candidiasis. Infect Immun 1995; 63: 2714–2719.
   PubMed Web of Science ®Google Scholar
• Bystricky S, Szu SC, Zhang J, Kovac P. Conformational differences among mono- and oligosaccharide fragments of O-specific polysaccharides of Vibrio cholerae O1 revealed by circular dichroism. Carbohydr Res 1998; 314: 135–139.
   PubMed Web of Science ®Google Scholar
• Classen DC, Morningstar JM, Shanley JD. Detection of antibody to murine cytomegalovirus by enzyme-linked immunosorbent and indirect immunofluorescence assays. J Clin Microbiol 1987; 25: 600–604.
   PubMed Web of Science ®Google Scholar
• Libjakova L, Bystricky S, Lizicarova I, Paulovicova E, Machova E. Evaluation of different mannan polysaccharide usage in enzyme-linked immunosorbent assay for specific antibodies determination. J Pharm Biomed Anal 2007; 45: 521–525.
   Google Scholar
• Paulovicova L, Bystricky S, Paulovicova E, . Model α-mannoside conjugates: immunogenicity and induction of candidacidal activity. FEMS Immunol Med Microbiol 2010; 58: 307–313.
   PubMedGoogle Scholar
• Kong YC, Levine HB. Experimentally induced immunity in the mycoses. Bacteriol Rev 1967; 31: 35–53.
   PubMedGoogle Scholar
• Torosantucci A, Chiani P, Bromuro C, . Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS One 2009; 4: e5392.
   PubMed Web of Science ®Google Scholar
• Liu M, Clemons K, Bystricky S, Stevens D. Glycans and conjugates as vaccines against coccidioidomycosis. In: 50th Interscience Conference on Antimicrobial Agents and Chemotherapy Boston, MA; 2010: Abst G1 – 1657.
   Google Scholar
• van de Veerdonk FL, Marijnissen RJ, Kullberg BJ, . The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009; 5: 329–340.
   PubMed Web of Science ®Google Scholar
• Brown GD, Gordon S. Fungal beta-glucans and mammalian immunity. Immunity 2003; 19: 311–315.
   PubMed Web of Science ®Google Scholar
• Cutler JE. Defining criteria for anti-mannan antibodies to protect against candidiasis. Curr Mol Med 2005; 5: 383–392.
   PubMed Web of Science ®Google Scholar
• Paulovicova E, Bystricky S, Masarova J, Machova E, Mislovicova D. Immune response to Saccharomyces cerevisiae mannan conjugate in mice. Int Immunopharmacol 2005; 5: 1693–1698.
   PubMed Web of Science ®Google Scholar
• Shibata N, Suzuki A, Kobayashi H, Okawa Y. Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms. Biochem J 2007; 404: 365–372.
   PubMed Web of Science ®Google Scholar
• Tojo M, Shibata N, Kobayashi M, . Preparation of monoclonal antibodies reactive with beta-1,2-linked oligomannosyl residues in the phosphomannan-protein complex of Candida albicans NIH B-792 strain. Clin Chem 1988; 34: 539–543.
   PubMed Web of Science ®Google Scholar
• Kedzierska A, Kochan P, Pietrzyk A, Kedzierska J. Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1-- > 3)-beta-D-glucan antigens. Eur J Clin Microbiol Infect Dis 2007; 26: 755–766.
   PubMed Web of Science ®Google Scholar
• Latge JP, Kobayashi H, Debeaupuis JP, . Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect Immun 1994; 62: 5424–5433.
   PubMed Web of Science ®Google Scholar